chr4-92304923-C-G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001510.4(GRID2):​c.88+179C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0683 in 152,122 control chromosomes in the GnomAD database, including 390 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.068 ( 390 hom., cov: 32)

Consequence

GRID2
NM_001510.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.0660

Publications

1 publications found
Variant links:
Genes affected
GRID2 (HGNC:4576): (glutamate ionotropic receptor delta type subunit 2) The protein encoded by this gene is a member of the family of ionotropic glutamate receptors which are the predominant excitatory neurotransmitter receptors in the mammalian brain. The encoded protein is a multi-pass membrane protein that is expressed selectively in cerebellar Purkinje cells. A point mutation in the mouse ortholog, associated with the phenotype named 'lurcher', in the heterozygous state leads to ataxia resulting from selective, cell-autonomous apoptosis of cerebellar Purkinje cells during postnatal development. Mice homozygous for this mutation die shortly after birth from massive loss of mid- and hindbrain neurons during late embryogenesis. This protein also plays a role in synapse organization between parallel fibers and Purkinje cells. Alternate splicing results in multiple transcript variants encoding distinct isoforms. Mutations in this gene cause cerebellar ataxia in humans. [provided by RefSeq, Apr 2014]
GRID2 Gene-Disease associations (from GenCC):
  • autosomal recessive spinocerebellar ataxia 18
    Inheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 4-92304923-C-G is Benign according to our data. Variant chr4-92304923-C-G is described in ClinVar as Benign. ClinVar VariationId is 1242806.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0822 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001510.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRID2
NM_001510.4
MANE Select
c.88+179C>G
intron
N/ANP_001501.2O43424-1
GRID2
NM_001440459.1
c.88+179C>G
intron
N/ANP_001427388.1
GRID2
NM_001286838.1
c.88+179C>G
intron
N/ANP_001273767.1O43424-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRID2
ENST00000282020.9
TSL:1 MANE Select
c.88+179C>G
intron
N/AENSP00000282020.4O43424-1
GRID2
ENST00000510992.5
TSL:1
c.88+179C>G
intron
N/AENSP00000421257.1O43424-2
GRID2
ENST00000505687.5
TSL:1
n.260+179C>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0683
AC:
10377
AN:
152004
Hom.:
388
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0443
Gnomad AMI
AF:
0.0680
Gnomad AMR
AF:
0.0862
Gnomad ASJ
AF:
0.0753
Gnomad EAS
AF:
0.0122
Gnomad SAS
AF:
0.0750
Gnomad FIN
AF:
0.0751
Gnomad MID
AF:
0.146
Gnomad NFE
AF:
0.0807
Gnomad OTH
AF:
0.0718
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0683
AC:
10384
AN:
152122
Hom.:
390
Cov.:
32
AF XY:
0.0685
AC XY:
5097
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.0446
AC:
1849
AN:
41502
American (AMR)
AF:
0.0861
AC:
1316
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0753
AC:
261
AN:
3466
East Asian (EAS)
AF:
0.0122
AC:
63
AN:
5162
South Asian (SAS)
AF:
0.0754
AC:
363
AN:
4812
European-Finnish (FIN)
AF:
0.0751
AC:
795
AN:
10588
Middle Eastern (MID)
AF:
0.136
AC:
40
AN:
294
European-Non Finnish (NFE)
AF:
0.0807
AC:
5486
AN:
67982
Other (OTH)
AF:
0.0705
AC:
149
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
489
978
1467
1956
2445
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
122
244
366
488
610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0262
Hom.:
15
Bravo
AF:
0.0674
Asia WGS
AF:
0.0510
AC:
176
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
3.9
DANN
Benign
0.63
PhyloP100
-0.066
PromoterAI
-0.00090
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs62310990; hg19: chr4-93226074; API